BioSpace
Partner Therapeutics announced last week that the FDA had granted Bizengri a Commissioner’s National Priority Voucher to accelerate drug review.
BioSpace
Partner Therapeutics announced last week that the FDA had granted Bizengri a Commissioner's National Priority Voucher to accelerate drug review.
BioSpace
Partner Therapeutics announced last week that the FDA had granted Bizengri a Commissioner’s National Priority Voucher to accelerate drug review.